PMC:7126544 / 63181-64187
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T516 | 92-100 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T517 | 92-96 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T518 | 149-157 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T519 | 384-392 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T520 | 384-388 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T521 | 479-487 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T522 | 880-888 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T523 | 880-884 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T524 | 989-997 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T525 | 989-993 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T531 | 317-320 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T532 | 598-600 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
| T533 | 615-616 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T534 | 701-704 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T535 | 771-774 | http://purl.obolibrary.org/obo/CLO_0054061 | denotes | 132 |
| T536 | 948-951 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T54351 | 0-2 | Chemical | denotes | Lu | http://purl.obolibrary.org/obo/CHEBI_33382 |
| T36207 | 17-27 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T63318 | 135-145 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T89 | 194-203 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T42873 | 223-226 | Chemical | denotes | FAD | http://purl.obolibrary.org/obo/CHEBI_16238|http://purl.obolibrary.org/obo/CHEBI_57692|http://purl.obolibrary.org/obo/CHEBI_73627 |
| T93 | 236-241 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T99302 | 276-291 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T42817 | 276-285 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T96 | 286-291 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T59656 | 337-347 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T98 | 352-363 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T62226 | 548-558 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T100 | 690-700 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T90532 | 777-779 | Chemical | denotes | Lu | http://purl.obolibrary.org/obo/CHEBI_33382 |
| T81387 | 835-846 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T7389 | 926-937 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T502 | 0-189 | Sentence | denotes | Lu reported that remdesivir may have the greatest potential for the successful treatment of SARS-CoV-2, but the efficacy and safety of remdesivir in COVID-19 needs further evaluation [135]. |
| T503 | 190-410 | Sentence | denotes | The antiviral efficiency of five FAD-approved drugs and two well-known broad-spectrum antiviral drugs have been studied and it has been found that remdesivir and chloroquine effectively inhibit SARS-CoV-2 in vitro [136]. |
| T504 | 411-602 | Sentence | denotes | The New England Journal of Medicine reported that the first case of COVID-19 confirmed in the United States was treated with intravenous remdesivir and demonstrated clinical improvement [71]. |
| T505 | 603-776 | Sentence | denotes | At present, a randomized, double-blind, placebo-controlled phase III clinical trial of remdesivir has been launched and already 761 confirmed cases have been enrolled [132]. |
| T506 | 777-897 | Sentence | denotes | Lu also pointed out that there is no direct evidence that oseltamivir is effective in the treatment of SARS-CoV-2 [135]. |
| T507 | 898-1006 | Sentence | denotes | However, we found that oral oseltamivir or abidol has been used for suspected or confirmed SARS-CoV-2 cases. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1650 | 92-102 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1651 | 384-394 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1652 | 880-890 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1653 | 989-999 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1654 | 17-27 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 1655 | 135-145 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 1656 | 223-226 | Chemical | denotes | FAD | MESH:D005182 |
| 1657 | 337-347 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 1658 | 352-363 | Chemical | denotes | chloroquine | MESH:D002738 |
| 1659 | 548-558 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 1660 | 690-700 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 1661 | 835-846 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 1662 | 926-937 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 1663 | 941-947 | Chemical | denotes | abidol | |
| 1664 | 149-157 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1665 | 479-487 | Disease | denotes | COVID-19 | MESH:C000657245 |